Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Règis Sodoyer
Introduction
Règis Sodoyer is a notable inventor based in Sainte Foy Les Lyon, France. He has made significant contributions to the field of immunology, particularly in the development of novel polypeptide antigens for therapeutic and prophylactic immunization against HIV-related infections. His work is characterized by a commitment to advancing medical science and improving public health.
Latest Patents
Règis Sodoyer holds a patent for the GP41 antigen. This invention comprises novel polypeptide antigens that mimic the intermediate state of gp41. The polypeptide is capable of inducing antibodies that neutralize primary isolates of HIV. The invention also includes compositions comprising the polypeptide and methods of using it, showcasing his innovative approach to combating HIV-related infections.
Career Highlights
Sodoyer is associated with Aventis Pasteur S.A., a leading company in the field of vaccines and immunization. His work at the company has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions. His dedication to research and development has positioned him as a key figure in the fight against HIV.
Collaborations
Throughout his career, Règis Sodoyer has worked alongside notable colleagues such as Michel Chevalier and Raphaëlle El Habib. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in immunology.
Conclusion
Règis Sodoyer's contributions to the field of immunology, particularly through his patent for the GP41 antigen, highlight his role as an influential inventor. His work continues to inspire advancements in therapeutic approaches to HIV-related infections.